Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,942
Closed -$1.38M 512
2025
Q4
$1.38M Buy
+7,942
New +$1.45M 0.17% 159
2024
Q4
Sell
-55,580
Closed -$4.06M 484
2024
Q3
$4.06M Sell
55,580
-13,907
-20% -$1.03M 0.48% 64
2024
Q2
$4.66M Buy
+69,487
New +$2.69M 0.57% 51
2020
Q4
Sell
-1,336
Closed -$43K 1022
2020
Q3
$43K Sell
1,336
-2,992
-69% -$86K 0.03% 463
2020
Q2
$119K Buy
4,328
+582
+16% +$13.8K 0.04% 448
2020
Q1
$60K Buy
3,746
+543
+17% +$12.9K 0.01% 729
2019
Q4
$76K Buy
+3,203
New +$65.2K 0.01% 806

Other funds holding INSM

FORA Capital's INSM Position: Q1 2026 in Review

FORA Capital sold out of Insmed (INSM) in Q1 2026, closing a stake of 7,942 shares — an estimated $1.38M sold.

FORA Capital first reported a position in INSM in Q4 2019 and held it in 7 quarters. The position peaked at $4.66M in Q2 2024. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • FORA Capital reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • FORA Capital sold 7,942 Insmed shares in Q1 2026, an estimated $1.38M.
  • FORA Capital first reported a position in Insmed in Q4 2019 and held it in 7 quarters.
  • FORA Capital's Insmed position peaked at $4.66M in Q2 2024.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.